4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-26-000096
Chief Executive Officer sold 75,000 shares at an average $26.14 ($1,960,601)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Congleton Jon Chief Executive Officer | 2026-06-30 | Sale 10b5-1 | −58,000 | $25.94 | $1,504,706 | 631,321 | D |
| Congleton Jon Chief Executive Officer | 2026-06-30 | Sale 10b5-1 | −17,000 | $26.82 | $455,896 | 614,321 | D |
| Open-market sales · 75,000 sh · avg $26.14 · $1,960,601 | |||||||
Loading xslF345X06/wk-form4_1782859282.xml…